Results
19
Companies which are more than 50% undervalued based on analyst price target.
19 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
HEIO | €60.05 | -0.5% | -14.9% | €17.0b | €111.60 | PE31.6x | n/a | 2.9% | Food, Beverage & Tobacco | ||
ALLFG | €5.37 | 2.1% | -7.7% | €3.3b | €8.51 | PE41.8x | E27.3% | 1.7% | Diversified Financials | ||
OCI | €11.24 | 2.7% | -46.3% | €2.4b | €18.26 | PS1.3x | E-15.3% | 14.9% | Materials | ||
FUR | €16.75 | -0.5% | -1.1% | €1.9b | €27.95 | PE6.5x | E3.7% | 2.4% | Capital Goods | ||
THEON | €10.42 | 7.2% | n/a | €729.4m | €16.50 | PE12x | E12.6% | 2.0% | Capital Goods | ||
TOM2 | €5.21 | 0.5% | -16.3% | €640.2m | €8.00 | PS1.1x | E112.2% | n/a | Software | ||
PHARM | €0.72 | 3.3% | -31.0% | €491.5m | €1.80 | PS1.8x | E73.2% | n/a | Pharmaceuticals & Biotech | ||
AMG | €14.29 | -5.4% | -33.6% | €460.2m | €23.41 | PS0.3x | E107.0% | 2.8% | Materials | ||
SIFG | €12.14 | 2.5% | 29.1% | €362.8m | €18.93 | PE31.8x | E78.4% | 0% | Capital Goods | ||
BSGR | €4.31 | 5.9% | 13.1% | €362.8m | €7.13 | PE9.1x | E19.5% | 3.7% | Retail | ||
ENVI | €4.76 | 0.8% | 76.3% | €274.6m | €7.79 | PE60.1x | E87.5% | n/a | Capital Goods | ||
NXFIL New | €4.10 | -3.6% | -34.9% | €238.0m | €6.65 | PS25.5x | E53.2% | n/a | Capital Goods | ||
CMCOM | €5.84 | -5.8% | -31.9% | €170.1m | €9.50 | PS0.6x | E108.9% | n/a | Software | ||
AVTX | €2.11 | -4.3% | -47.4% | €167.7m | €5.21 | PS7.8x | E10.6% | n/a | Commercial Services | ||
BAI | €0.73 | -2.7% | 32.7% | €89.0m | €2.50 | PS15.3x | E58.7% | n/a | Pharmaceuticals & Biotech | ||
CABKA | €2.54 | 0% | -58.9% | €62.8m | €4.88 | PS0.3x | E84.8% | 5.9% | Materials | ||
VVY | €2.00 | -1.7% | -74.4% | €52.0m | €23.23 | PB3.7x | E5.1% | n/a | Pharmaceuticals & Biotech | ||
CTAC | €2.72 | 2.3% | -20.0% | €38.5m | €5.10 | PE35.2x | E45.7% | 4.0% | Software | ||
EBUS | €0.91 | -25.8% | -97.2% | €13.3m | €42.25 | PS0.1x | E75.2% | n/a | Capital Goods |